Neuroretinal Biomarkers for Schizophrenia Spectrum Disorders

PURPOSE: We evaluated the patient-control differences and predictive value of the retina as potential biomarkers for schizophrenia. METHODS: The institutional study included both eyes of 58 schizophrenia spectrum disorder (SSD) patients (age 37.2 ± 12.3 years) and 35 controls (age 41.1 ± 15.2 years)...

Descripción completa

Detalles Bibliográficos
Autores principales: Asanad, Samuel, O'Neill, Hugh, Addis, Hampton, Chen, Shuo, Wang, Jingtao, Goldwaser, Eric, Kochunov, Peter, Hong, L. Elliot, Saeedi, Osamah J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083086/
https://www.ncbi.nlm.nih.gov/pubmed/34004009
http://dx.doi.org/10.1167/tvst.10.4.29

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083086/
https://www.ncbi.nlm.nih.gov/pubmed/34004009
http://dx.doi.org/10.1167/tvst.10.4.29

Ejemplares similares